The skeletal muscle fibre membrane plays a major role in muscle contraction by generating and propagating action potentials, and linking the latter to the release of intracellular calcium stores which triggers mechanical contraction. This function relies on the proper functioning of ion channels. In the last two decades, diseases caused by mutations in muscle ion channel genes have been identified, the so-called muscle channelopathies. Even though the pathophysiology of muscle channelopathies is not completely elucidated, major advances have been made in their understanding, thus linking patient symptoms and neurophysiology with abnormal functioning of the muscle membrane. This has facilitated significant progress both in the diagnosis of these disorders and in the rationale for therapeutic intervention. In this review, we will focus on diagnosis and treatments of muscle channelopathies of relevance to the clinical neurologist.

Diagnosis and new treatment in muscle channelopathies / G. Meola, M.G. Hanna, B. Fontaine. - In: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. - ISSN 0022-3050. - 80:4(2009 Apr), pp. 360-365. [10.1136/jnnp.2008.164046]

Diagnosis and new treatment in muscle channelopathies

G. Meola
;
2009

Abstract

The skeletal muscle fibre membrane plays a major role in muscle contraction by generating and propagating action potentials, and linking the latter to the release of intracellular calcium stores which triggers mechanical contraction. This function relies on the proper functioning of ion channels. In the last two decades, diseases caused by mutations in muscle ion channel genes have been identified, the so-called muscle channelopathies. Even though the pathophysiology of muscle channelopathies is not completely elucidated, major advances have been made in their understanding, thus linking patient symptoms and neurophysiology with abnormal functioning of the muscle membrane. This has facilitated significant progress both in the diagnosis of these disorders and in the rationale for therapeutic intervention. In this review, we will focus on diagnosis and treatments of muscle channelopathies of relevance to the clinical neurologist.
hypokalemic periodic paralysis; sodium-channel mutations; Andersen-Tawil-syndrome; skeletal-muscle; paramyotonia-congenita; chloride channel; nondystrophic myotonias; alpha-subunit; gene SCN4A; potassium
Settore MED/26 - Neurologia
apr-2009
Article (author)
File in questo prodotto:
File Dimensione Formato  
J Neurol Neurosurg Psychiatry-2009-Meola-360-5.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 205.63 kB
Formato Adobe PDF
205.63 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/146446
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 15
social impact